« Return to News | CROs/Service Providers

MPI Research, Edge partner on brain hemorrhage therapies

Friday, April 6, 2012 09:57 AM

MPI Research, the world’s largest single-site preclinical CRO, and Edge Therapeutics, a hospital-focused biopharmaceutical company, will collaborate on preclinical and clinical testing of Edge's lead product candidates to advance life-saving therapies after brain hemorrhaging.

The companies will combine their skills and expertise with the goal of initiating clinical trials of Edge's portfolio of therapies—NimoGel, NimoVent and EG-1964—that use novel implantable technology to deliver proven drugs directly to the site of brain injury.

The collaboration creates a preferred partnership relationship in which MPI Research will act as Edge's primary service provider for pharmacologic, analytical and safety in preclinical testing, and will also provide analytical services for clinical testing. This collaboration will allow Edge to gain multiple cost efficiencies while still retaining asset ownership and ownership of its strategic decision-making.

"Partnering with MPI Research allows Edge to access additional expertise and capabilities on a larger scale, helping to advance our lead hospital products into clinical trials," said R. Loch Macdonald, MD, PhD, chief scientific officer of Edge. "We look forward to a strong collaboration focused on the shared goal of saving the lives of brain-injured patients."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.